((2R,3S,5R)-3-Hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl trihydrogen diphosphate disodium salt

Catalog No. :
ACDPMG683
CAS No. :
28120-41-4
Molecular Formula :
C10H16N2Na2O11P2
Molecular Weight :
448.17

IUPAC Name:((2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl trihydrogen diphosphate, disodium salt

((2R,3S,5R)-3-Hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl trihydrogen diphosphate disodium salt structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$176.00Login to see priceInquiryInquiry
250mg95%$356.00Login to see priceInquiryInquiry
1g95%$597.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name((2R,3S,5R)-3-Hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl trihydrogen diphosphate disodium salt
IUPAC Name((2R,3S,5R)-3-hydroxy-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl trihydrogen diphosphate, disodium salt
Molecular FormulaC10H16N2Na2O11P2
Molecular Weight448.17
SMILESO=C1N([C@@H]2O[C@H](COP(OP(O)(O)=O)(O)=O)[C@@H](O)C2)C=C(C)C(N1)=O.[Na].[Na]
InChI KeyYRDGURQEQMIBHE-ZJWYQBPBSA-N
SynonymThymidine 5'-(trihydrogen diphosphate), sodium salt (1:2);dTDP Disodium Salt;dTDP 100mM Sodium Solution
CAS No.28120-41-4

Synthetic Route by SureRoute

1. ACDPMG683 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDPMG683 route product structure diagram
    ACDPMG68328120-41-4
Inquiry

2. ACDPMG683 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDPMG683 route product structure diagram
    ACDPMG68328120-41-4
Inquiry

Comments (0)